Ask VialBase
immune

Crystagen

FDA: not-FDA-approved

Crystagen is a thymus bioregulator peptide that supports immune system balance by modulating gene expression in thymus tissue. Part of the Khavinson peptide family, it provides anti-inflammatory, regenerative, and immunoprotective effects, especially in aging or immunocompromised individuals. Thymus bioregulator peptide that modulates gene expression in thymus tissue. Has anti-inflammatory, regenerative, and immunoprotective effects. Supports immune system balance particularly in aging or immune-compromised individuals. Operates epigenetically to maintain thymic function and immune cell education. - Immune system optimization - Thymic regulation and support - Anti-inflammatory effects - Longevity support - Immunoprotection in aging - Standard: 10-20 mg per cycle, orally or

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number —
Route —
02

Sourcing

Current prices

Updated today

20mg

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC with differential
DURING CYCLE
  • CBC with differential
POST-CYCLE
  • CMP
  • CBC
Safety & Regulatory Status
FDA STATUS not-FDA-approved

Regulatory status for Crystagen may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.